$80M Boost for Kent County Housing 🚀

In partnership with

The
Daily Trade

Former PepsiCo Exec Invented A Plastic That Dissolves in Water

If anyone knows a thing about plastic’s impact on the planet, it’s Manuel Rendon. The former PepsiCo executive and environmental engineer is using his 20 years of expertise to solve one of the world’s biggest problems with Timeplast.

Up to 450 million metric tons of plastic are wasted each year. Microplastics seep into our bodies, and mountains of bottles pile up in the ocean. But Timeplast has patented a water-soluble, time-programmable plastic that vanishes without harming the environment.

Major players are already partnering with Timeplast for its patented technology—their sales grew 6,000% in the first month.

You have just a few days left to invest as Timeplast scales in its $1.3T plastic market, from packaging to 3D printing. Become a Timeplast shareholder by midnight, 7/31.

This is a paid advertisement for Timeplast’s Regulation CF Offering. Please read the offering circular at invest.timeplast.com.

Hey Daily Traders,

Real Estate takes center stage today as the Michigan State Housing Development Authority Board injects nearly $80 million into Kent County housing projects. This funding, aimed at creating or preserving vital housing units, underscores a significant push to address housing shortages and support local economies, with projects like HōM Flats in Wyoming and 21 Weston in Grand Rapids leading the way.

In Finance, Azimut Group's acquisition of North Square Investments marks a pivotal expansion into the U.S. market, promising enhanced distribution and product offerings. Meanwhile, Phlow Corp.'s $37 million funding round highlights a critical investment in U.S. medicine manufacturing, showcasing a commitment to innovation and supply chain resilience.


Here's what's happening today:

  • 🏠 $80M boosts Kent County housing projects
  • 🤝 Azimut acquires North Square Investments
  • 💊 Phlow secures $37M for medicine manufacturing
  • 🎁 +10 more business & investing news stories you might like
  • 📊 +4 technical analysis results

Question

Do you think the $80 million investment in Kent County housing projects will significantly alleviate the local housing shortage, or is more needed to meet demand?

Reply to this email with your answer

Partner

A pro traders #1 rule when trading options

Scott Redler has spent 30 years mastering one thing: sticking to a proven strategy. And with over 200k followers, he’s helped others trade stocks.

Now, he’s finally cracking open his options playbook for the masses to see. That’s because volatility in the markets makes options a winning strategy. Plus a recent 423% winner on BABA in 1 day! It’s about understanding risk vs. reward.

Scott is sharing exactly how he does it in a free report & 15-minute video.

Download your FREE report NOW.

Real Estate

In a significant move to enhance housing availability, the Michigan State Housing Development Authority Board has approved nearly $80 million for three housing projects in Kent County. The funding aims to create or preserve housing units to meet the needs of Michigan's residents. Among the projects, HōM Flats in Wyoming received $39 million to build 200 units, including 12 accessible ones, targeting households earning 40% to 70% of the area median income.

Additionally, the board allocated $18.5 million for the acquisition and rehabilitation of Countryside Townhouses in Kentwood, and $21.4 million for 21 Weston in Grand Rapids to rehabilitate 96 units. These projects are part of a broader effort to create stronger communities by expanding housing stock across the state. The developments are expected to support the local economy and cater to diverse income groups, reflecting progress in addressing housing shortages.

Key Takeaway
  • The $80 million funding for Kent County housing projects represents a significant investment opportunity in the real estate sector.
  • By addressing housing shortages, these projects could lead to increased property values and economic growth in the region.
Finance

Azimut Group, a major European asset manager, has announced its acquisition of North Square Investments, a Chicago-based investment firm. This strategic move strengthens Azimut's presence in the U.S., making it a critical market after Italy. The acquisition will enable Azimut to leverage North Square's distribution capabilities and expand its product offerings, including global equity, fixed income, and alternative investments.

The deal signifies a cultural and strategic alignment between the two firms, both known for their entrepreneurial spirit and innovative approach. With the acquisition, North Square will be renamed Azimut NSI and will see its assets under management rise to over $20 billion. This transaction is expected to close in early 2026, subject to regulatory approvals, marking a new chapter of growth for both companies.

Key Takeaway
  • Azimut's acquisition of North Square Investments highlights a growing trend of international asset managers expanding into the U.S. market.
  • This move could offer investment opportunities in diversified asset management strategies and broaden access to global investment products.
Healthcare

Phlow Corp., a key player in the American pharmaceutical manufacturing sector, has successfully closed a $37 million Series C financing round. Led by Align Private Capital, the funds will support Phlow's mission to enhance U.S.-based medicine development and manufacturing. The investment will be used to scale technology-driven innovation, including AI-powered systems and next-generation pharmaceutical manufacturing technologies.

This funding comes at a crucial time as Phlow aims to strengthen domestic production of essential pharmaceutical ingredients. With over $93 million raised in private capital and significant government contracts, Phlow is positioned to address inefficiencies in the U.S. pharmaceutical supply chain, including preventing pediatric drug shortages and supporting military needs. The company's growth reflects investor confidence in its vision to revolutionize medicine manufacturing in America.

Key Takeaway
  • Phlow's $37 million funding round underscores the increasing importance of domestic pharmaceutical manufacturing.
  • Investors may find opportunities in companies like Phlow that are innovating to secure supply chains and meet critical healthcare needs.

More Business & Investing news


  • ⚡ Talen Energy reports PJM auction results (Link)
  • 📈 Auburn National's Q2 shows growth (Link)
  • 🧑‍⚖️ Fortrea Holdings class action deadline (Link)
  • 🛢️ Brett Icahn joins SandRidge Energy board (Link)
  • 📊 Sanuwave Health to present at conference (Link)
  • 💵 Century Aluminum closes $400M notes offering (Link)
  • 🌏 Aspida Re expands with Japan transaction (Link)
  • 🌱 New investments by Grand Rapids VC fund (Link)
  • 🏨 Thomas Financial secures $19.975M loan for hotel (Link)
  • 🌱 New investments by Grand Rapids VC fund (Link)

Today's Technical Analysis



Undervalued
NOK
Nokia Corporation
Volume: 86.15M shares | Price: $4.46

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Buy

Undervalued
MOH
Molina Healthcare, Inc.
Volume: 2.29M shares | Price: $180.64

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Overvalued
TPR
Tapestry, Inc. Common Stock
Volume: 4.27M shares | Price: $106.25

Technical Indicator Score: 88% Sell
Out of the 8 technical indicators used to analyze this stock, 7 indicated sell signals, 1 indicated a neutral signal.
RSI
Sell
MFI
Sell
WillR
Sell
AO
Sell
CCI
Sell
BBANDS
Hold
ULTOSC
Sell
STOCH
Sell

Overvalued
IVZ
Invesco LTD
Volume: 16.43M shares | Price: $21.25

Technical Indicator Score: 88% Sell
Out of the 8 technical indicators used to analyze this stock, 7 indicated sell signals, 1 indicated a neutral signal.
RSI
Sell
MFI
Sell
WillR
Sell
AO
Sell
CCI
Sell
BBANDS
Sell
ULTOSC
Sell
STOCH
Hold

You might also like…

We’re always looking for opportunities to bring our readers more value so we’ve partnered with a handful of companies that we think you might enjoy.

If you have suggestions for companies we should partner with, let us know and we’ll reach out to them.

Thanks for Reading!

Have ideas to improve our newsletter? Let us know 

Want to reach our readers? Become a sponsor

Was this email forwarded to you? Subscribe here

How would you rate today's newsletter?

If there's anything I can do better, please reply to this email and let me know!

Login or Subscribe to participate in polls.

Technical Indicator Information

Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30

Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20

Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80

Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75

Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal

Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20

Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100

Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band

Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price

Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0

Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30

Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI

Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25

Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.

Disclaimers and Disclosures

The information contained in this newsletter is for informational and educational purposes only and is not intended to constitute investment advice or to address the individual financial circumstances or objectives of any subscriber. Nothing in this publication should be construed as a solicitation, offer, or recommendation to buy or sell any security, investment product, or financial instrument. All opinions expressed herein are solely those of the publisher and are subject to change without notice.

We strongly recommend that you consult with a qualified financial advisor, tax professional, or legal counsel before making any investment decisions. Investing involves risk, including the potential loss of principal. Past performance is not indicative of future results.

Some investment opportunities or companies featured in this newsletter may be presented through paid sponsorships or partnerships. If an opportunity is sponsored or we have a financial relationship with the issuer or promoter, we may or may not disclose this clearly. However, inclusion of any such opportunity does not constitute an endorsement or recommendation, and you should assume that we may have a financial interest in some of the opportunities discussed.

You should not rely solely on the information presented in this newsletter to make any investment decision. You are solely responsible for your own due diligence, investment decisions, and the evaluation of the risks involved. We are not liable for any losses or damages — direct, indirect, incidental, or consequential — arising from any reliance placed on the information in this newsletter, including but not limited to any investment or business decision you make based on such information.

Although we obtain information from sources we believe to be reliable, we do not warrant its accuracy, completeness, or timeliness. Any data, commentary, or analysis may be incomplete, outdated, or not reflect current market conditions, including after-hours trading, material news, or broader economic developments.

This newsletter and all of its content are the proprietary information and property of The Daily Trade and are licensed solely for the personal, individual use of each subscriber. Any unauthorized distribution, reproduction, forwarding, or quotation of the content herein is strictly prohibited.

By reading this newsletter, you agree to the above terms and acknowledge and accept the inherent risks of investing.